CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 15 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $41,000 | -42.3% | 106,172 | 0.0% | 0.00% | – |
| Q4 2019 | $71,000 | +69.0% | 106,172 | 0.0% | 0.00% | – |
| Q3 2019 | $42,000 | -26.3% | 106,172 | 0.0% | 0.00% | – |
| Q2 2019 | $57,000 | -46.7% | 106,172 | -7.0% | 0.00% | – |
| Q1 2019 | $107,000 | +55.1% | 114,157 | +0.2% | 0.00% | – |
| Q4 2018 | $69,000 | -86.6% | 113,964 | -69.8% | 0.00% | – |
| Q3 2018 | $516,000 | -2.5% | 376,897 | +1.2% | 0.00% | – |
| Q2 2018 | $529,000 | +4.5% | 372,497 | -0.4% | 0.00% | – |
| Q1 2018 | $506,000 | -16.2% | 374,155 | +7.7% | 0.00% | – |
| Q4 2017 | $604,000 | +27.7% | 347,446 | +34.5% | 0.00% | – |
| Q3 2017 | $473,000 | +224.0% | 258,420 | +568.4% | 0.00% | – |
| Q2 2017 | $146,000 | -70.9% | 38,665 | -73.6% | 0.00% | – |
| Q1 2017 | $501,000 | +7.3% | 146,505 | +66.1% | 0.00% | – |
| Q4 2016 | $467,000 | +66.2% | 88,191 | +88.1% | 0.00% | – |
| Q3 2016 | $281,000 | -26.1% | 46,884 | -38.1% | 0.00% | – |
| Q2 2016 | $380,000 | – | 75,786 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|